These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38841701)
21. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial. Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B; JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665 [TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473 [TBL] [Abstract][Full Text] [Related]
23. Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion. Zhang Y; Wu Z; Wang S; Liu T; Liu J Cardiovasc Drugs Ther; 2023 Dec; 37(6):1155-1166. PubMed ID: 35930211 [TBL] [Abstract][Full Text] [Related]
24. Comparison of two different drug-coated balloons for the treatment of in-stent restenosis: A long-term single-centre experience. Benezet J; Agarrado A; Gutiérrez-Barrios A; Ruiz-Fernandez D; Del Río A; Cañadas D Cardiovasc Revasc Med; 2016; 17(3):176-80. PubMed ID: 26916568 [TBL] [Abstract][Full Text] [Related]
25. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions. Scheller B; Mangner N; Abdul Kader MASK; Wan Ahmad WA; Jeger R; Wöhrle J; Ong TK; Liew HB; Gori T; Mahfoud F; Nuruddin AA; Woitek F; Abidin IZ; Schwenke C; Schnorr B; Mohd Ali R Circ Cardiovasc Interv; 2022 Sep; 15(9):e012305. PubMed ID: 36126132 [TBL] [Abstract][Full Text] [Related]
26. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559 [TBL] [Abstract][Full Text] [Related]
27. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
29. Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. Harada Y; Colleran R; Pinieck S; Giacoppo D; Michel J; Kufner S; Cassese S; Joner M; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA EuroIntervention; 2017 Apr; 12(17):2132-2139. PubMed ID: 27916742 [TBL] [Abstract][Full Text] [Related]
30. A randomized comparison of a novel iopromide-based paclitaxel-coated balloon Shenqi versus SeQuent Please for the treatment of in-stent restenosis. Zhu J; Liu L; Zhu Z; Yang Z; Hu J; Ding F; Zhou Y; Su X; Ge J; Liu X; Tang L; He Y; Zhou G; Ji Z; Li Y; Pang W; Zhang R Coron Artery Dis; 2021 Sep; 32(6):526-533. PubMed ID: 33229940 [TBL] [Abstract][Full Text] [Related]
31. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881 [TBL] [Abstract][Full Text] [Related]
32. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model. Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810 [TBL] [Abstract][Full Text] [Related]
33. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions. Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017 [TBL] [Abstract][Full Text] [Related]
34. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176 [TBL] [Abstract][Full Text] [Related]
35. SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry. Assadi-Schmidt A; Mohring A; Liebsch E; Dannenberg L; Achilles A; Pöhl M; Afzal S; Veulemans V; Horn P; Sansone R; Bönner F; Levkau B; Kelm M; Zeus T; Polzin A Int J Cardiol; 2017 Mar; 231():68-72. PubMed ID: 28089147 [TBL] [Abstract][Full Text] [Related]
36. Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study. Masuda H; Kuramitsu S; Ito T; Morofuji T; Domei T; Hyodo M; Shirai S; Ando K Catheter Cardiovasc Interv; 2022 Nov; 100(6):990-999. PubMed ID: 36229982 [TBL] [Abstract][Full Text] [Related]
37. [Interventional treatment of symptomatic intracranial in-stent restenosis]. Wu ZH; Qiu HC; Hu SS; Liu AF; Wang K; Zhou J; Zhang YQ; Zhang YY; Liu F; Xiang L; Jiang WJ Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(37):3017-3020. PubMed ID: 30392260 [No Abstract] [Full Text] [Related]
38. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease. Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study. Gruber P; Braun C; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Berberat J; Remonda L J Neurointerv Surg; 2019 Jul; 11(7):719-722. PubMed ID: 30415229 [TBL] [Abstract][Full Text] [Related]
40. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise. Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]